アンチトロンビンIII antithrombin III
WordNet
- 100 at equal 1 kip in Laos
- the 9th letter of the Roman alphabet (同)i
- the 1st letter of the Roman alphabet (同)a
- the blood group whose red cells carry the A antigen (同)type_A, group A
PrepTutorEJDIC
- 《場所・位置のある一点》『…で』,『…に』 / 《時間・年齢・目盛りなどの一点》『…に』,『…で』 / 『…の最中で』,に出席して / 『…の状態に』(『で』) / 『…を目指して』,に向かって / 《移動の経路》…を通って,…から / 《動作・感情などの原因・理由・動機》『…によって』,…を見て(聞いて,知って) / 《運動・動作の方法・様態》…で,…のやり方で / 《数量・割合・率》…で,…に / 《能力・性質などの存在場所》…が,…の点で
- 『私は』私が
- iodineの化学記号
- answer / ampere
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Anticoagulant and antithrombotic activities of low-molecular-weight propylene glycol alginate sodium sulfate (PSS).
- Xin M1, Ren L1, Sun Y1, Li HH1, Guan HS1, He XX2, Li CX3.
- European journal of medicinal chemistry.Eur J Med Chem.2016 May 23;114:33-40. doi: 10.1016/j.ejmech.2016.02.063. Epub 2016 Mar 2.
- Propylene glycol alginate sodium sulfate (PSS), a sulfated polysaccharide derivative, has been used as a heparinoid drug to prevent and treat hyperlipidemia and ischemic cardio-cerebrovascular diseases in China for nearly 30 years. To extend the applications of PSS, a series of low-molecular-weight
- PMID 26974373
- Colorectal cancer survival by stage of cases diagnosed in Mallorca, Spain, between 2006 and 2011 and factors associated with survival.
- Ramos M1, Montaño J2, Esteva M3, Barceló A4, Franch P4.
- Cancer epidemiology.Cancer Epidemiol.2016 Apr;41:63-70. doi: 10.1016/j.canep.2016.01.001. Epub 2016 Jan 29.
- OBJECTIVES: To establish cause-specific survival by stage of colorectal cancer up to 8 years from diagnosis, and to identify factors which explain and predict the likelihood of survival.METHODOLOGY: Retrospective follow-up study of people diagnosed with invasive colorectal cancer during 2006-2011, i
- PMID 26828896
- Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis.
- Allingstrup M1,2, Wetterslev J3, Ravn FB4, Møller AM5, Afshari A4,5.
- Intensive care medicine.Intensive Care Med.2016 Apr;42(4):505-20. doi: 10.1007/s00134-016-4225-7. Epub 2016 Feb 9.
- PURPOSE: Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties. We assessed the benefits and harms of AT III in critically ill patients.METHODS: We searched from inception to 27 August 2015 in CENTRAL, MEDLINE, EMBASE, CAB, BIOSIS and CINAHL. We included randomized contr
- PMID 26862016
Japanese Journal
- P1-23-7 下肢深部静脈血栓(DVT)のコントロールに難渋し,大量のヘパリンとAT-III製剤を必要とした抗リン脂質抗体症候群(APS)合併妊娠の1例(Group23 合併症妊娠1,一般演題,公益社団法人日本産科婦人科学会第66回学術講演会)
- 松尾 愛理,池田 亜貴子,古田 希,河原 俊介,泉 有希子,三瀬 有香,芦原 隆二,堀内 緑,長野 英香,川島 直逸,吉岡 信也
- 日本産科婦人科學會雜誌 66(2), 531, 2014-02-01
- NAID 110009811814
- 末梢前庭障害様所見を呈した正常圧水頭症によるめまいと考えられた1例
- 道祖尾 弦,隈上 秀高,髙橋 晴雄
- Equilibrium Research 73(6), 528-532, 2014
- … An equilibrium test was carried out at a later date under the suspicion of right vestibular neuronitis, however, no decline in semicircular canal function was observed upon caloric testing, with no difference between the left and right observed as well upon vestibule-ocular reflex (VOR), and so a follow-up was carried out with a diagnosis of vertebrobasilar insufficiency. …
- NAID 130004910886
- 先天性アンチトロンビン欠乏症患者の大動脈弁置換術における周術期管理の経験
- 田上 可桜,齋藤 綾,木下 修,川島 大,柴田 深雪,師田 哲郎,本村 昇,小野 稔
- 日本心臓血管外科学会雑誌 43(3), 101-104, 2014
- … 行した.入院時AT活性53%と低値であり,ワーファリン投与を中止の上AT III製剤補充とヘパリン投与を行い手術に臨んだ.術当日はAT活性>80%に維持し,通常どおりACT値を基にヘパリンを用いた人工心肺管理を行い得た.周術期はワーファリンによる抗凝固療法を再開して,PT-INRが目標域に達するまでAT III製剤を補充しな …
- NAID 130004887194
Related Pictures
★リンクテーブル★
[★]
[★]
[★]
[★]
[★]
[★]
アンチトロンビンIII